Founders Capital Management (Texas)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.32M | Buy |
25,101
+406
| +2% | +$87.3K | 2.73% | 15 |
|
|
2026
Q1 | $5.37M | Sell |
24,695
-76
| -0.3% | -$16.9K | 2.62% | 16 |
|
|
2025
Q4 | $5.66M | Sell |
24,771
-125
| -0.5% | -$28.5K | 2.94% | 14 |
|
|
2025
Q3 | $5.76M | Sell |
24,896
-277
| -1% | -$56.4K | 3.05% | 12 |
|
|
2025
Q2 | $4.67M | Sell |
25,173
-148
| -0.6% | -$27.5K | 2.8% | 14 |
|
|
2025
Q1 | $5.31M | Sell |
25,321
-6,208
| -20% | -$1.21M | 3.43% | 13 |
|
|
2024
Q4 | $5.6M | Sell |
31,529
-1,090
| -3% | -$200K | 3.55% | 10 |
|
|
2024
Q3 | $6.44M | Sell |
32,619
-239
| -0.7% | -$44.6K | 3.92% | 9 |
|
|
2024
Q2 | $5.64M | Sell |
32,858
-622
| -2% | -$103K | 3.65% | 9 |
|
|
2024
Q1 | $6.1M | Sell |
33,480
-297
| -0.9% | -$51.2K | 4.12% | 6 |
|
|
2023
Q4 | $5.23M | Sell |
33,777
-364
| -1% | -$53.1K | 3.8% | 7 |
|
|
2023
Q3 | $5.09M | Sell |
34,141
-1,484
| -4% | -$218K | 3.89% | 7 |
|
|
2023
Q2 | $4.8M | Buy |
35,625
+47
| +0.1% | +$6.89K | 3.49% | 8 |
|
|
2023
Q1 | $5.67M | Sell |
35,578
-372
| -1% | -$56.9K | 4.34% | 6 |
|
|
2022
Q4 | $5.81M | Buy |
35,950
+9
| +0% | +$1.38K | 4.37% | 6 |
|
|
2022
Q3 | $4.82M | Sell |
35,941
-276
| -0.8% | -$39.6K | 3.94% | 7 |
|
|
2022
Q2 | $5.55M | Sell |
36,217
-2,315
| -6% | -$354K | 4.37% | 4 |
|
|
2022
Q1 | $5.22M | Hold |
38,532
| – | – | 3.34% | 6 |
|
|
2021
Q4 | $5.22M | Sell |
38,532
-279
| -0.7% | -$33K | 3.34% | 6 |
|
|
2021
Q3 | $4.19M | Sell |
38,811
-3,017
| -7% | -$345K | 2.87% | 9 |
|
|
2021
Q2 | $4.71M | Sell |
41,828
-280
| -0.7% | -$31.5K | 3.07% | 8 |
|
|
2021
Q1 | $4.56M | Sell |
42,108
-2,090
| -5% | -$224K | 3.24% | 8 |
|
|
2020
Q4 | $4.74M | Buy |
+44,198
| New | +$4.25M | 3.35% | 8 |
|
|
2020
Q1 | $3.82M | Sell |
50,124
-5,879
| -10% | -$501K | 3.96% | 5 |
|
|
2019
Q4 | $4.96M | Buy |
56,003
+8,960
| +19% | +$744K | 3.75% | 6 |
|
|
2019
Q3 | $3.56M | Buy |
47,043
+2,910
| +7% | +$200K | 2.85% | 12 |
|
|
2019
Q2 | $3.21M | Sell |
44,133
-47
| -0.1% | -$3.69K | 2.83% | 12 |
|
|
2019
Q1 | $3.56M | Buy |
44,180
+215
| +0.5% | +$17.6K | 3.34% | 10 |
|
|
2018
Q4 | $4.05M | Sell |
43,965
-220
| -0.5% | -$19.3K | 4.33% | 5 |
|
|
2018
Q3 | $4.18M | Sell |
44,185
-70
| -0.2% | -$6.64K | 3.45% | 6 |
|
|
2018
Q2 | $4.1M | Sell |
44,255
-739
| -2% | -$72.2K | 3.6% | 6 |
|
|
2018
Q1 | $4.26M | Sell |
44,994
-1,000
| -2% | -$110K | 3.59% | 3 |
|
|
2017
Q4 | $4.45M | Sell |
45,994
-690
| -1% | -$65K | 3.69% | 3 |
|
|
2017
Q3 | $4.15M | Buy |
46,684
+330
| +0.7% | +$25.1K | 3.44% | 3 |
|
|
2017
Q2 | $3.36M | Buy |
46,354
+1,275
| +3% | +$85.7K | 2.98% | 4 |
|
|
2017
Q1 | $2.94M | Buy |
+45,079
| New | +$2.83M | 2.64% | 6 |
|
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Founders Capital Management (Texas)'s ABBV Position: Q2 2026 in Review
Founders Capital Management (Texas) increased its AbbVie (ABBV) stake by 1.6% in Q2 2026, buying an estimated $87.3K and bringing the position to 25,101 shares worth $6.32M. The position accounts for 2.73% of the portfolio, ranked #15.
Founders Capital Management (Texas) first reported a position in ABBV in Q1 2017 and has held it in 36 quarters since. The position peaked at $6.44M in Q3 2024. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Founders Capital Management (Texas) held 25,101 shares of AbbVie worth $6.32M as of Q2 2026.
- Founders Capital Management (Texas) bought 406 AbbVie shares in Q2 2026, an estimated $87.3K.
- AbbVie made up 2.73% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #15 holding.
- Founders Capital Management (Texas) first reported a position in AbbVie in Q1 2017 and has held it in 36 quarters since.
- Founders Capital Management (Texas)'s AbbVie position peaked at $6.44M in Q3 2024.
- 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.